Drug Database
Back to search

United States· US:50268-350_42522f26-564b-a89e-e063-6394a90a3ffc

Gemfibrozil

A gemfibrozil product containing gemfibrozil, registered in United States by AvPAK. The same ATC class is registered in 12 of our 19 countries.

ATC C10AB04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGemfibrozilATCC10AB04REGISTER NO.US:50268-350_42522f26…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gemfibrozilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gemfibrozil is registered in 12 of 19 countries.

Countries holding a registration under ATC C10AB04 (gemfibrozil), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search gemfibrozil products by name

Gemfibrozil · ATC C10AB04

12 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gemfibrozil costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Gemfibrozil · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • FR France$0.50
  • IT Italy$0.42
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GEMFIBROZIL
Manufacturer
AvPAK
Country
United States (US)
ATC code
C10AB04
ATC class
Gemfibrozil
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    50268-350-15
  • ndc11
    5026835015
    50 BLISTER PACK in 1 BOX (50268-350-15) / 1 TABLET in 1 BLISTER PACK (50268-350-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

165 interactions on record for gemfibrozil.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gemfibrozil against other medicinesHow interaction checks work

Gemfibrozil · interactions on record

165 records

  • 19 severe
  • 57 moderate
  • 2 minor
  • 85 info

Most severe, free to view

  • LoperamideA07DA03severe
  • EluxadolineA07DA06severe
  • PioglitazoneA10BG03severe
  • RepaglinideA10BX02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gemfibrozil in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gemfibrozil products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Gevilon
  • Cyprus · Ipolipid, Lipofor
  • Denmark · Lopid
  • Spain · Gemfibrozilo Stada, Gemfibrozilo Tarbis
  • France · Lipur
  • United Kingdom (Northern Ireland) · Gemfibrozil Tillomed Laboratories, Lopid
  • Greece · Fibrolip, Gemlipid
  • Ireland · Lopid
  • Iceland · Lopid
  • Italy · Gemfibrozil Doc Generici, Gemfibrozil Eg
  • Netherlands · Gemfibrozil Aurobindo, Lopid
  • Portugal · Gemfibrozil Generis, Lopid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2d00422-abf3-418e-95ff-681652e15480
GET /v1/drugs/b2d00422-abf3-418e-95ff-681652e15480?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600",
  "substance": "GEMFIBROZIL",
  "productndc": "50268-350",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077836",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about gemfibrozil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console